Latest News

News

COVID-19 vaccine for infants: antibodies persist a year on

During the COVID-19 pandemic immunisation of infants has been a highly contentious and confusing issue. From initial advice ...

Pfizer/Valneva Lyme disease vaccine persists 6 months on

On 1st December 2022 Pfizer and Valneva reported antibody persistence data 6 months after vaccination with their Lyme ...

Africa CDC gets mpox vaccine donation from Republic of Korea

During a meeting between Acting Director General of Africa CDC, and KDCA Commissioner it was announced that the ...

HDT Bio and UTMB partner against CCHFV and NiV

In November 2022 HDT Bio Corp. and the University of Texas Medical Branch (UTMB) revealed that they had ...

Marking World AIDS Day 2022: “equalise” theme

1st December 2022 is World AIDS Day, with global communities observing it under the theme “equalise”. This year, ...

US announces further Global Health Security Partnerships

White House issued a statement indicating the intention of the Biden-Harris Administration to continue to “prioritise global health ...

PharmaJet announces grant from NIH for HPV

PharmaJet announced that it had received an NIH grant towards their Phase II investigation of the immunogenicity of ...

WHO approval for Republic of Korea regulator

The WHO announced in November that the Ministry of Food and Drug Safety (MFDS), Republic of Korea, achieved ...

CEPI collaboration with UQ on Disease X platform

In November 2022 CEPI announced an investment of U$5.7 million towards the development of a second-generation molecular clamp ...

WHO: Monkeypox virus gets rebranded as Mpox

The WHO announced in November 2022 that, after “consultations with global experts”, it will begin using a preferred ...

Exclusive interview with Dr Ariel Weinberger

With the World Vaccine and Immunotherapy Congress just days away we are delighted to share another exclusive interview ...

UK applies Vaccine Taskforce model to health problems

The UK government announced in November 2022 that it would be introducing a “Vaccine Taskforce style approach” to ...

Group A strep kills child in England with another recovering

In November 2022 it was reported that a child, around the age of 6, had died after catching ...

Universal flu vaccine hopes renewed in new data

A study published in Science in November 2022 has given experts in the UK reason to predict that ...

WHO declares measles a dangerous “growing threat”

The WHO announced that almost 40 million children were “dangerously susceptible” to the “growing threat” of measles following ...

Relief from UTIs offered by sublingual vaccine

A research paper published in Science Advances suggests the possibility of UTI prevention through a sublingual vaccine. The ...

Vaccines: the missing piece in the dementia puzzle?

Dementia is described by the NHS as a syndrome associated with an “ongoing decline of brain functioning”. This ...

Exclusive interview with Dr Stephen Johnston

As we gear up towards the World Vaccine and Immunotherapy Congress in San Diego later this month we ...

AELIX Therapeutics study in Nature meets endpoints

In November 2022 the results of the AELIX-002 trial were published in Nature by collaborators from Aelix Therapeutics ...

WHO launches AMR strategy in Africa during awareness week

WHO launched a strategy to “respond to the urgent problem of antimalarial drug resistance in Africa”. This coincided ...

Exclusive interview with Dr Andrew Vaillant

As we look forward to future events, a conversation with Dr Andrew Vaillant links our event in Barcelona ...

Glioblastoma vaccine offers longer life to patients

In a study, researchers collaborated to demonstrate “clinically meaningful and statistically significant extension of survival” for patients ...

Exclusive interview with Dr Erin Spiegel

While we were in Barcelona this year for the World Vaccine Congress 2022 we had the exciting opportunity ...

WHO on vaccine safety: it’s a “shared responsibility”

In November 2022 the WHO, with “financial support” from USAID, finalised a project on vaccine safety monitoring in ...

Hepatitis E vaccination campaign offers hope in South Sudan

Reported by Epicentre, a group “embedded” in Médecins sans frontières (MSF), progress is being made in a joint ...

WHO publishes Global Vaccine Market Report 2022

In November 2022 the WHO shared its Global Market Vaccine Report for the year 2022. It is the ...

Fentanyl vaccine shows therapeutic promise in rats

A study by researchers led by the University of Houston demonstrates potential to eliminate the high caused by ...

A very modern challenge: The Human Immunome Project

“Pioneering a new era of human health”, scientists at the Human Immune Project are tackling “one of the ...

Breast cancer vaccine: safe at Phase I trial

A study in JAMA Oncology in November 2022 suggests that researchers in the US are making progress with ...

New collaboration: AI steps up to pandemic plate

In November 2022 CEPI and the University of California, Davis announced a partnership agreement to “advance and expand ...

Exclusive interview with Dr Christian Brander

Another highlight from this year's World Vaccine Congress in Europe was the opportunity to speak to Dr Christian ...

WHPA and WHO sign memorandum of understanding

On 8th November 2022 the WHO and the 5 members of the World Health Professions Alliance (WHPA) signed ...

LUMC and ISA study generates “strong” results

A publication in October 2022 by researchers at LUMC investigated the safety and immunogencity of ISA therapeutic vaccine ...

Exclusive interview with Dr Carl Dieffenbach

As we continue sharing interviews that took place during the World Vaccine Congress in Europe 2022 we are ...

GSK Shingrix vaccine success drives ¾ revenues

A November press release from GSK indicates a rise and revenue in profit, attributed to its Shingrix vaccine ...

Study shows vaccine confidence sinking after COVID-19

A study by researchers at the University of Portsmouth in Vaccine at the end of October explored the ...

Senescent cell potential against cancer revealed

Researchers in Europe published results in Cancer Discovery in November 2022 that indicate promising responses to vaccination with ...

CEPI-Gavi-WHO collaboration during Ebola outbreak

Over a month after the declaration of an Ebola outbreak in Uganda in September 2022 the WHO, CEPI, ...

Nature study: vaccine selfishness cost lives

From the start of the COVID-19 pandemic it was clear that each of us would have a different ...

Calls for ASEAN AVRF to move forward from COVID-19

In November 2022 a commentary in The Lancet Global Health reflected that COVID-19 vaccination programmes have been “relatively ...

Vaxxinity platform aims to conquer chronic diseases

Migraines affect an estimated 10% of people worldwide, causing severe headaches and other symptoms such as light sensitivity, ...

Exclusive interview with Dr Jerome Kim

In the aftermath of the World Vaccine Congress in Europe 2022 we are delighted to present the second ...

Thinking bee: oral vaccination against AFB in honeybees

According to a study in Frontiers in Veterinary Science in October 2022, an oral vaccination study in honeybees ...

Sanofi deploys Dassault’s virtual twin experiences

In October 2022 Sanofi and Dassault Systemes announced a partnership to optimise Sanofi’s “EVolutive Facilities” (EVF). These are ...

WHO publishes first list of fungal priority pathogens

In October 2022 the WHO published a report that highlights the “first-ever” list of fungal priority pathogens. This ...

Ukraine receives 700,000 Td doses from UNICEF

The UN Office for the Coordination of Humanitarian Affairs (OCHA) reported in October 2022 that UNICEF had delivered ...

Senegal launches programme for measles and rubella vaccine

The Institut Pasteur de Dakar in Senegal announced in October 2022 that it was creating a new vaccine ...

On Polio Day PharmaJet announces USAID grant

The 24th of October 2022 was World Polio Day, which draws attention to the continued global fight against ...

British farmers call for bird flu vaccinations

After security measures against avian flu were lifted in Great Britain in August 2022 the outbreak has continued ...

Gavi CEO calls for vaccine market “interventions”

Dr Berkley, CEO of Gavi, the global alliance pursuing vaccine equity, wrote in the Financial Times in October ...

Merck finds frozen Ebola vaccines to test in Uganda spread

As Uganda’s Ebola outbreak continues to claim lives the need for a vaccine grows greater. The outbreak was ...

WHO and IDIA renew agreement for health impact

In October 2022 the WHO announced the renewal of a strategic Collaboration Agreement with the International Innovation Alliance ...

African swine fever: the deadly pig pandemic

First detected in East Africa in the early 1900s, ASF has a high mortality rate in domestic pigs. ...

Cholera vaccine supply issues disrupt double-dose regime

The WHO announced in October 2022 that the International Coordinating Group on Vaccine Provision will “suspend” its standard ...

Exclusive interview with Dr Jerald Sadoff

After a fantastic few days at the World Vaccine Congress we at Vaccine Nation are just getting our ...

Vaccine efforts: the thorn in Polio’s side?

Original efforts for Polio eradication have been unsuccessful. Gavi reports that it was “supposed to be eradicated 22 ...

WHO launches One Health Joint Plan of Action

In October 2022 the WHO, as part of a wider Quadripartite, launched a One Health Joint Plan of ...

Airfinity predicts jab price increase to meet demand

In October 2022 the health analytics specialist Airfinity predicted that the COVID-19 vaccine market will generate $60 billion ...

BioNTech founding duo anticipate mRNA against cancer

Speaking to Laura Kuenssberg of the BBC, Professors Sahin and Tureci indicated that mRNA treatments against cancers could ...

GSK announces positive results for RSV candidate

In a press release on 13th October 2022 GSK plc announced “positive pivotal phase III trial results” for ...

Reports of increasing dangerous pathogen labs

An article in Nature suggested that “in the wake” of the COVID-19 pandemic and consequences, an increase in ...

Japan’s 100-day ambitions funded in SCARDA

Japan’s Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response SCARDA announced investment ...

Cancer therapy or prevention: where should we focus?

An article in the New York Times in October 2022 reflects that developing a cancer vaccine for high-risk ...

Mouse model mRNA success for hereditary tyrosinemia 1

A German study published in September 2022 supports “periodic low-dose intramuscular administration” of an mRNA-based therapy against Hereditary ...

Oxford study shows meningitis vaccine leads to herd immunity

In October 2022 a group of researchers from the University of Oxford reported the effects of the UK’s ...

Menstruation after COVID-19 vaccination: tracking changes

Research published in BMJ Medicine in August 2022 reflected a collaboration to investigate the effects of COVID-19 vaccination ...

US study: adults believe vaccine is protective against flu

A 2022 study by the US National Foundation for Infectious Diseases found that “most adults believe annual flu ...

CEPI announces funding for intranasal vaccines

In October 2022 CEP and the Dutch vaccine developer Intravacc announced funding to for broad protection against variants ...

Oxford study reveals lung change after COVID-19

A study from the University of Oxford, published in the Journal of Applied Physiology in September 2022 investigated ...

South African vaccine attempt slammed by pharma giants

During the COVID-19 pandemic the stark inequalities of our world were highlighted by disparities in vaccine development, production, ...

Moderna denies China access to vaccine technology

In October 2022 the Financial Times reported that Moderna had refused China’s request for the intellectual property behind ...

Australian collaborators awarded contract for TB vaccines

The Centenary Institute in Sydney and the University of Sydney announced in September that they had been awarded ...

Gavi reports vaccine drop in 2021 but 2022 shows promise

In September 2022 Gavi reported a second consecutive year of decreased routine immunisation across 57 countries. However, early ...

Zika vaccine technology shows mouse model promise

Results published in Microbiology Spectrum by researchers from the US demonstrate that their Zika vaccine technology is safe ...

Vaxxas to receive further funding for patch technology

Vaxxas announced in September 2022 that it will receive an AU$8.2 million grant from the Australian Federal Government ...

Misinformation and myths: identifying key culprits

In March 2021 the Centre for Countering Digital Hate (CCDH) published a report that identified “leading online anti-vaxxers". ...

Gates Foundation announces grants for maternal vaccines

In September 2022 the Bill & Melinda Gates Foundation announced its investment in the “development and accessibility” of ...

Marking World Heart Day 2022: healthy hearts and vaccines

29th September will be World Heart Day 2022. This is a day of attention to how we can ...

Looming “twindemic” prompts calls for more shots

Experts have warned that an early and sustained wave of flu will hit the United Kingdom this year ...

Still searching for vaccines: mRNA against cancer

Several our recent articles have focused on the role of vaccination in cancer therapies. Initially we considered some ...

Marking World Rabies Day 2022: One Health, Zero Deaths

28th September 2022 is World Rabies Day, with this year’s theme being “One Health, Zero Deaths”. To mark ...

Sanofi: single-use systems offer speedier manufacturing

In an interview with Pharma Logistics IQ, Sanofi’s Ken Wong spoke to Leila Hawkins about the opportunities that ...

Immune imprinting: a help or a hindrance?

In an interview for the Human Vaccines Project in September 2022, Kristen Jill Abboud spoke to Professor Deepta ...

Exclusive interview with Dr Charlie Weller

Here at the World Vaccine Congress, we are looking forward to our next event in Barcelona in October ...

WHO announces 2023 influenza vaccine recommendation

In September 2022 the WHO announced its recommendation for the viral composition of influenza vaccines for the 2023 ...

Exclusive interview with Dr Miguel Sanjuan

With just a few weeks left until the World Vaccine Congress we are looking forward to hearing from ...

Sabin announces further BARDA funding for trials

In September 2022 the Sabin Vaccine Institute announced that it was “receiving an additional $21.8 million” from the ...

Long Covid: more questions than answers, studies suggest

An article by Gavi in September 2022 explored the few studies that investigate the links between COVID-19 vaccination ...

Global Fund Partners announce record funding against disease

In September the US hosted a “pledging conference” for the Global Fund to Fight AIDS, Tuberculosis, and Malaria. ...

Uganda declares Ebola outbreak of ‘Sudan’ strain

In September 2022 the WHO announced that health authorities in Uganda had declared an outbreak of Ebola. This ...

CEPI launches funding for Rift Valley fever trials

In September 2022 CEPI announced the launch of its second phase of funding to “advance innovative Rift Valley ...

White paper from SGS: vaccine development post-pandemic

In a white paper from SGS in September 2022 the importance of “analytical biosafety testing” and “advances in ...

European biotechs receive EUREKA therapeutic funding

In September 2022 LABIOTECH.EU announced that a partnership between European biotech companies had been awarded a €1.06 million ...

Fauci’s warning: politics disrupts childhood immunisation

Dr Anthony Fauci warned that tension caused by the politicisation of the COVID-19 vaccination programme could affect routine ...

Biden declares pandemic over, sends shares plummeting

In September 2022 Biden declared in a 60 Minutes broadcast that the “pandemic is over”. Despite acknowledging that ...

Marking WHO’s World Patient Safety Day 2022

On September 17th the WHO marks World Patient Safety Day: safe maternal and new-born care. The World Health ...

mRNA giants launch therapeutic protein ambitions

Published in Nature in September 2022, Ken Garber explores the hopes of mRNA companies who are setting their ...

Holding out hope: a therapeutic prostate cancer vaccine

In Nature in September 2022 an article by Anthony King identified the difficulties associated with creating an immunotherapy ...

World Vaccine Congress Europe 2022: meet our start-ups!

In its 23rd year the World Vaccine Congress Europe is set to be one of our biggest and ...

HHS announces $20 million contract for faster distribution

In September the US HHS announced it was “significantly expanding the number of locations nationwide that can be ...

COVID marathon end in sight, says WHO Director General

The WHO Director General reflected in his weekly press conference in early September that the end of the COVID-19 ...

Inventprise to launch pneumonia vaccine with Gates support

The WHO reported in 2021 that pneumonia accounted for 14% of all deaths of children under 5, the ...

Pfizer’s Phase III flu trial begins in US

Pfizer announced in September 2022 that the first participants in its “pivotal” Phase III influenza trial had been ...

Genexine announces DNA vaccine for cervical cancer

Genexine, a Korean biopharmaceutical company, announced in August that its “first-in-class proprietary DNA vaccine” demonstrated efficacy and safety ...

Q Fever cases increase in Queensland, Australia

Q Fever, or ‘Query’ fever, was first identified in Australia in the 1930s as workers at a meat ...

WHO approves PharmaJet NFIS for polio campaigns

At the end of August 2022, PharmaJet announced that the WHO had chosen its Tropis Needle-free Injection System ...

Prof. Hotez: malnutrition vaccines for a hungry world

An article by Professor Hotez in Trends in Pharmacological Sciences in September 2022 explored the demand and potential ...

New COVID boosters: a risk to vaccine confidence?

The Financial Times warned in September that health experts in the US were concerned about the COVID-19 booster ...

CEPI funding COVID vaccine research and development

It is well-known that the need to develop vaccines, or rather a vaccine, against future iterations of COVID-19, ...

NIAID announces JYNNEOS monkeypox vaccine trial

NIAID announced in September 2022 that a clinical trial “evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine” ...

New HIV strategy in adjuvanted vaccine study

HIV is widely considered to present the scientific community with a “daunting scientific challenge”, as stated by Dr ...

Pfizer’s GBS6 receives Breakthrough Therapy Designation

Pfizer announced in September 2022 that its investigational Group B Streptococcus vaccine candidate, GBS6, had received Breakthrough Therapy ...

Positive results in trial for malaria vaccine from Oxford

Results published in The Lancet Infectious Diseases in September 2022 demonstrated “high efficacy” for a booster vaccine against ...

Oncolytic viruses hold immunotherapy potential

An article in In Vivo explored the potential of OVs, crediting “relatively safe mode of action” and possibility ...

Exclusive interview with Professor Carlos A. Guzman

We hear from Professor Carlos Guzman, head of Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection ...

WHO launches vaccine development portal: STI Watch

At the 23rd IUSTI World Congress in September 2022 the first online portal on vaccine development for sexually ...

CanSino Biologics announces NMPA approval of inhaled booster

In early September 2022 CanSino Biologics Inc. announced that the National Medical Products Administration of China (NMPA) had ...

Tomato flu: a mystery no more, say experts

In a previous article on the mysterious “tomato flu” or “tomato fever” in Kerala, India, we explored how ...

PAHO monitors bilateral pneumonia in Argentina

On 30th August the Ministry of Health in Argentina informed the WHO/PAHO that it had been notified of ...

Australian therapy centre provides pandemic solutions

The Cumming Global Centre for Pandemic Therapies (CGCPT) launched on 31st August 2022, thanks to a donation of ...

Floods in Pakistan present disease potential, warns UN

WHO Director General Dr Tedros Adhanom Ghebreyesus announced on 31st August that the WHO had classified current flooding ...

Pregnancy misinformation prevails but vaccine still safe

In August 2022 UK health agencies had to clarify that the recommendation for covid vaccination during pregnancy has ...

IAVI announces beginning of Lassa trial with CEPI

IAVI announced in August 2022 that volunteers for the PREVAIL clinical trial have been vaccinated with a novel ...

From Africa, for Africa: Aspen and Serum partnership

Africa’s Centre for Disease Control and Prevention suggests that less than 1% of the vaccines used in Africa ...

VACCELERATE partners explore vaccine outreach

The European Vaccine Initiative, working with VACCELERATE partners, published findings of an “Inventory and gap analysis report of ...

Lung fluid offers cancer diagnostic and treatment options

Researchers from the Technicon-Israel Institute of Technology and Sheba Medical Centre published in the Journal for ImmunoTherapy of ...

Control/elimination/eradication: Covid-19/monkeypox/polio

In August 2022 Dr Hans Henri P Kluge, WHO Regional Director for Europe, outlined three actions on three ...

Antiretroviral approved for drug resistant HIV treatment

In August 2022 an article for NAM’s Aidsmap detailed the approval of Gilead Sciences’ long-acting HIV capsid inhibitor ...

Pfizer and BioNTech respond to Moderna’s lawsuits

Following Moderna’s announcement that it would be filing patent infringement lawsuits against Pfizer and BioNTech, the two companies ...

Takeda’s dengue vaccine approved in Indonesia

Indonesia’s National Agency for Drug and Food Control approved Takeda’s dengue vaccine candidate in August 2022. The vaccine, ...

Moderna files lawsuits against Pfizer and BioNTech

Moderna announced that it was filing lawsuits against Pfizer and BioNTech. On 26th August, Moderna suggested that the ...

Pfizer announces RENOIR RSV Phase III data

Pfizer announced that the Phase III clinical trial of RENOIR demonstrated “positive data”. RSV vaccine Efficacy iN Older ...

Tomato flu affecting more children across India

As India grapples with a “probable emergence of fourth wave” of Covid-19, a new virus has entered the ...

GREENER Pharma: the criteria for sustainable healthcare

In an article published in August 2022 researchers from Europe proposed “GREENER” criteria for reducing the effects of ...

Shooting for the moon: cancer therapies from CLS

The US President Joe Biden announced in February his intention to reignite his 2016 Cancer Moonshot mission. The ...

WHO approval for Chinese vaccine regulator

The WHO announced in August that the National Medical Products Administration (NMPA) has achieved maturity level three (ML3) ...

University students reminded to check jabs off their list

The UK Health Security Agency (UKHSA) reminded university students to ensure their vaccinations are up to date before ...

HDT Bio’s saRNA collaboration advances cancer technology

HDT Bio, a developer of immunotherapies for oncology and infectious diseases, announced in August 2022 that it is ...

Oxford group investigates potential monkeypox therapy

A group of researchers at the University of Oxford are investigating the therapeutic potential of an antiviral called ...

Valneva’s progress towards chikungunya vaccine

In August 2022 Valneva SE, a speciality vaccine company based in France, announced that it has “initiated rolling ...

Launch of Rotavirus vaccine in Nigeria celebrated globally

A report by DefeatDD, which aims to address the issues caused by diarrhoea, comments that “the day we ...

One Health research proposals in South-East Asia

The Australian Centre for International Agricultural Research (ACIAR) and Canada’s International Development Research Centre (IDRC) have come together ...

Oxford study explores resistance to cancer therapy

A study in Nature Communications in August 2022 presented an investigation by researchers at Oxford University. They explored ...

WHO Ebola guideline coincides with DRC case

The WHO published its first guideline for Ebola virus disease therapeutics in August 2022, coinciding with a reported ...

Study in Nature explores mRNA Covid-19 vaccine and HIV

A study published in Nature stated that research into curing HIV focuses on “reactivating latent proviruses to enable ...

World Vaccine Congress Europe 2022: meet our start-ups!

In its 23rd year the World Vaccine Congress Europe is set to be one of our biggest and ...

GSK awarded malaria vaccine contract by UNICEF

The pharmaceutical company GSK was awarded a contract for the first supply of a malaria vaccine by UNICEF ...

Malawi’s cholera outbreak sustained through winter

The beginning of Malawi’s cholera outbreak in March 2022 came at the end of rainy season. A spokesperson ...

Bavarian Nordic capacity increased with US manufacturer

Bavarian Nordic announced in August 2022 that it had “entered into an agreement” with GRAM to expand capacity ...

UNITAID’s “Landscape” of tools and strategies

UNITAID published a report to examine the "tools and interventions” to prevent mother-to-child transmission of HIV, syphilis, hepatitis ...

UK’s first human Brucella canis case confirmed

The European Scientific Counsel Companion Animal Parasites called for compulsory testing of imported dogs after the UK’s first ...

WHO updates guidance for Tuberculosis response

In August 2022 the WHO announced new guidance to “support national strategic planning” for TB responses. This guidance ...

UK’s JCVI updates Covid-19 booster programme

In August 2022 the Joint Committee on Vaccination and Immunisation (JCVI) published advice on the boosters that will ...

White paper from IDT Biologika: oncolytic viruses

In a white paper for IDT Biologika Dr Heidi Trusheim and Trevor Broadt examine the process of developing ...

mRNA vaccine for cancer shows promise at Tufts University

A study in PNAS in August 2022 presented an mRNA vaccine for cancer that targets the lymph nodes ...

Avian influenza restrictions lifted in the UK

The UK’s Chief Veterinary Office, Professor Christine Middlemiss, is appealing to bird keepers to maintain enhanced biosecurity measures. ...

UK approves Moderna’s dual vaccine against Covid

The UK Medicines and Healthcare products regulatory Agency (MHRA) announced in August that it had approved Moderna’s bivalent ...

University partners find MND therapy potential

Researchers announced in August 2022 that they found evidence that the drug terazosin “protects against the death of ...

White paper from IDT Biologika: viral vectors

In a white paper Dr Neubert explores how viral vectors offer a host of opportunities for vaccine development ...

Study reveals Covid-19 vaccinations safe for pregnancy

A study published in The Lancet in August 2022 concluded that Covid-19 vaccinations had a “good safety profile”. ...

CEPI driving research into monkeypox vaccines

In July CEPI announced that it would provide $375,000 to “support the development of key laboratory tools to ...

Professor Hotez warns against anti-vaccine activism

In August 2022 Dr Peter Hotez wrote an article in Nature exploring the dire consequences of America’s “anti-vaccine ...

Langya (LayV) henipavirus emerges in China

Langya (LayV) is a henipavirus. According to an article in New Scientist it appears to be “most closely ...

The monkeypox vaccine: how much do we know?

As monkeypox cases across the world continue to increase, rollouts of the one licensed vaccine are under pressure. ...

Tired T-cells need TLC to continue fighting cancer

When providing an immune response to cancer T-cells are known to get “exhausted” to the point of no ...

Pan-coronavirus vaccine hopes boosted by cold immunity

Scientists at La Jolla Institute for immunology have concluded that patients with a stronger immune response to the ...

Positive partnerships for malaria prevention

Malaria threatens almost half of the world’s population, with the WHO estimating that the number of deaths in ...

AI turns its sights to drug discovery challenges

The WHO states that cancer is a “leading cause of death worldwide”. It accounted for nearly 1 in ...

Climate health is global health, study concludes 

In August 2022 a study published in Nature concluded that 58% of infectious diseases that we face have ...

Lyme disease vaccine candidate proceeds to Phase III study

Lyme disease is a systemic infection transmitted to humans by infected ticks. It is caused by the Borrelia ...

Immune system map uncovers therapeutic potential

A group of scientists, led by researchers at the Wellcome Sanger Institute and ETH Zurich, created a “comprehensive ...

Improving protein factories for gene therapies

Gene therapy tackles the source of disease in the patient’s DNA through viral or bacterial vectors. Most commonly, ...

UKHSA under vaccine pressure as monkeypox continues

LGBTQ+ groups across a spectrum of political parties wrote to the Health and Social Care Secretary Steve Barclay ...

Antimicrobial resistant bacteria discovered in new-borns

A study published in Nature Microbiology in 2022 explored the links between the presence of antimicrobial resistant bacteria ...

Emerging emergencies require top authority

In July 2022 the Director-General of the WHO, Dr Tedros Adhanom Ghebreyesus, declared monkeypox to be a Public ...

Monkeypox doses stretched to the limit by NIH scientists

As global cases of monkeypox continue to increase, it is evident that vaccine demand is greater than the ...

Vertex’s “Fantasy project” with Moderna pushes CF limits

Vertex Pharmaceuticals and Moderna announced in 2022 their collaboration aimed at the “discovery and development of lipid nanoparticles ...

Experimental RSV vaccine promise shown in mice

The respiratory syncytial virus (RSV) infects almost all children before they turn 2 years old. The pathogen causes ...

“Shot to the heart” (of mutating viruses)

As the Covid-19 pandemic continues in myriad variants, current vaccine technology is struggling to keep up. Often employing ...

2030 AIDS elimination goals for new WHO alliance

The recent UNAIDS report revealed that only 52% of children with HIV are receiving life-saving treatment. This number ...

Gavi’s reasons to be optimistic: routine rises

After woeful statistics of global vaccine uptake, and the news that the AIDS response is “under threat”, GAVI ...

Science suggests components for pandemic disruption treaty

WHO member states can expect an update from an Intergovernmental Negotiating Body in August on an "initial draft" ...

Continuing the Covid-19 fight with monoclonal antibodies

As the Covid-19 pandemic continues sweeping across the globe, variants mutate and rise against current treatments. Protection afforded ...

Hear from our WVC 2022 speaker: Dr Jennifer Nuzzo

DrPh Jennifer Nuzzo, Professor at Brown University School of Public Health warned that the world is not ready ...

WHO’s new infection guidelines for “key populations”

In July 2022 the WHO published new guidelines on “HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and ...

Northern Europe’s novel hepatitis nightmare

In April 2022 cases of acute hepatitis of “unknown origin” in children were reported across the WHO European ...

Hear from our WVC 2022 speaker: Dr David Kaslow

Dr David Kaslow, CSO of PATH, suggested the success of vaccines against future pandemics relied on leaders developing ...

Hear from our WVC 2022 speaker: Dr James Crowe

Dr Crowe, Director of the Vanderbilt Vaccine Centre and presenter at the World Vaccine Congress explained discoveries in ...

Twist Bioscience turns to monkeypox controls

Twist Bioscience has launched two monkeypox synthetic DNA controls that are estimated to provide 80% coverage of the ...

Back to the past: Polio pops up again in 2022

Although unrelated vaccine-like polio is found in the UK sewage every year, recent samples were different to the ...

Prioritising pathogens in a pandemic world

The WHO list of priority diseases sets out the diseases and pathogens that research and development in “public ...

Solving supply chain safety and sustainability concerns

As we experience healthcare crisis after healthcare crisis the need for safe and sustainable supply chains is more ...

Vaccine inequity strikes Africa once again

It appears that the clear lessons from the Covid-19 pandemic have been blatantly ignored, certainly regarding vaccine distribution. ...

Demanding sustainable subscriptions for AMR

An article by Drs Till Boularte and Ulrik Schilze of BCG stated that “when market forces fail to motivate ...

China’s antiviral pill: from HIV to Covid-19

In July 2022 China’s drug regulator gave conditional approval for Azvduine, an HIV drug developed by Genuine Biotech, ...

Operation Warp Speed is a wrap: farewell to funding

In typical American fashion (no offence – we're all just envious...) the US Covid-19 vaccination programme took the ...

Rabies results from Oxford University trial

On 28th July 2022 researchers from the University of Oxford reported positive results from a Phase I clinical ...

Danger ahead! The forgotten pandemic: AIDS

The warning from UNAIDS released in July 2022 featured an alarming front cover, with the words “in danger” ...

Together against Alzheimer’s: where do we stand?

Some of the most common indicators of Alzheimer’s disease include build-ups of beta-amyloid plaques, tau proteins, and neuroinflammation. ...

Vaccine fatigue: are we nearly there yet?

We’ve pushed against vaccine hesitancy, encouraged increased uptake of dose after dose, booster after dose. Booster after booster. ...

A universally acknowledged flu requires a universal vaccine

Literary references aside, flu is about as universal a truth as it gets; each year ‘flu season’ rears ...

Marburg virus: more to come or a fleeting moment?

A WHO Collaborating Centre in Senegal confirms from two samples that Ghana is experiencing its first outbreak of ...

Expecting the unexpected: preparing for Disease X

Of the 1.67 million viruses on the planet, scientists know of about 0.04%. Between 631,000 and 827,000 are ...

AMR – global problems require diagnostic solutions

AMR was declared by the WHO to be one of the top 10 global health threats to humanity, ...

Noses to the grindstone for nasal vaccines

Writing in Science in July 2022 Dr Eric Topol and Dr Akiko Iwasaki reflected on the “unprecedented success” ...

Clinical tribulations – how can we grow from Covid-19?

Clinical trials are a critical stage in development, and during the Covid-19 pandemic we watched vaccines hurtle through ...

VIE: looking back to last year’s winners!

The World Vaccine Congress in Washington DC, April 2022, was a resounding success with record numbers of attendees ...

A helping hand from double, double toil and trouble

Audiuvare – to help. Calling to mind a group of earnest lab assistants, the word adjuvant describes ingredients ...

Vaccines: more than just a “sharp scratch”?

When most of us think of vaccines we have visions of a nurse with a sharp needle, homing ...

High hopes for collaborative HIV vaccine development

In March 2022 Dr Anthony Fauci, director of NIAID, reflected that developing an effective HIV vaccine is a ...

Diabetes developments, Provention and Diamyd

Historic diabetes treatment focuses on treating the condition with insulin, but recent immunotherapies have been moving to delay ...

Does EBV hold the key for Multiple Sclerosis?

Multiple Sclerosis (MS) affects the central nervous system in among 2.8 million people worldwide, yet the underlying cause ...

Fighting hidden threats: vaccines against cancer? 

Vaccines provide the immune system with information to recognise and fight threats before they appear in the body. ...

Global vaccine uptake: low, slow, room to grow

The Covid-19 pandemic has swept across the world with impunity over the past three years, bringing to light ...

Me before you before us: vaccine nationalism

The word stockpiling marked its place the public vocabulary thanks to its increased used during the Covid-19 pandemic. ...

Why are covid vaccinations in pregnant women so low?

The Covid-19 pandemic presented the scientific community with one of the fastest changing challenges of the 21st century. ...

Marking World Hepatitis Day, 28th July 2022

World Hepatitis Day is on July 28th, marking the birthday of Dr Baruch Blumberg, the Nobel-prize winning scientist ...
vaccine hesitancy solutions

Fighting fear with facts or feelings? Vaccine hesitancy.

In our previous article on vaccine hesitancy, we identified the ‘5Cs’ associated with a reluctance or refusal to ...
monkeypox

Monkeypox matters – preventing the next pandemic?

In May 2022, Monkeypox cases in non-endemic countries were reported, with 1,856 confirmed cases in the UK as ...
vaccine hesitancy

Immune to the science? The ‘5C’ drivers of vaccine hesitancy

Vaccine hesitancy is described by SAGE as a “delay in acceptance or refusal of vaccines despite availability of ...
MOST POPULAR THIS MONTH